Health IT

Ottawa's first national eye care strategy isn't just about health. It's a calculated investment in economic resilience and systemic stability for an aging nation.

Digital health firm Osara Health is targeting the 'Cancer Care Cliff,' backing its new survivorship program with a validated 25:1 ROI and proven health outcomes.

Zealand Pharma's petrelintide shows double-digit weight loss with remarkably few side effects, positioning it to challenge GLP-1 giants in the $100B market.

DBV Technologies heads to a key investor conference with its VIASKIN patch for peanut allergies. Can its science and strategy convince Wall Street?

Ottawa unveils a multi-billion dollar plan to transform Canada from an AI research hub into an economic leader, focusing on adoption, sovereignty, and ethics.

Ottawa's new "AI for All" plan promises to revolutionize healthcare, but can its 'ironclad protections' keep pace with the technology it's unleashing?

A new alliance between General Fluidics and Invetech seeks to move lab testing from centralized facilities to the clinic, promising faster, more accessible care.

A breakthrough biomarker, DNlite™, analyzes landmark trial data, offering a new way to identify high-risk diabetes patients missed by current standards.

With Brian Ewart's appointment as General Counsel, the nonprofit signals a new era of disciplined growth, leveraging top legal talent to navigate complex federal contracts.

As Chip McLeod succeeds a 39-year veteran at Bank of America's Upstate SC helm, his deep local ties signal a strategic push beyond banking into community-driven growth.

Florida Southern College secures a rare 10-year nursing accreditation, signaling a critical boost for a state grappling with a persistent nursing shortage.

With its new SYNMUE™ probiotic, SynbioTech is targeting the biological clock of our immune system. A deep dive into the science, the strategy, and the execution.

As NY Tech Week buzzes with AI, a SoHo pop-up offers a glimpse into a future where work, fitness, and recovery are one seamless, data-driven loop. But at what cost?

With key regulatory decisions pending in Canada and the US, DIAGNOS's CARA AI platform is set to unlock a multi-billion dollar market for early eye disease detection.

A new book by a space-shuttle-scientist-turned-ecologist reveals the complex systems that make Tampa Bay a resilient asset and a modern cautionary tale.

Aiper's new partnership with charity: water isn't just philanthropy. It's a calculated move to link its backyard tech to the global water crisis, turning eco-conscious consumers into brand evangelists.

Market research shows doctors are eager to prescribe Moleculin's new AML drug, Annamycin. It offers hope where there is none, but can the company survive to deliver it?

With 460,000 providers enrolled, Careviso is tackling healthcare's most hated process. A case study shows it's cutting case times by more than half.

Amid a regional healthcare crisis, 475 nurses at BMC South plan to picket, citing unsafe staffing and a 'bullying' contract offer from management.

A new partnership aims to revolutionize battery safety by sniffing out fires before they start. But can this defense-grade tech scale for our battery-powered world?